APOTEEK TERMOTE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTEEK TERMOTE
Largest movements
- Receivables within one year +€50,917
up €50,917 (+45.0%), from €113,134 to €164,051
of which Trade receivables: +€35,162
- Cash +€17,580
up €17,580 (+9.7%), from €181,753 to €199,333
mainly Net result for the year (+€50,423) and Trade debts (+€13,854)
- Stocks and contracts +€13,338
up €13,338 (+15.5%), from €86,061 to €99,399
- Deferred charges and accrued income -€10,376
down €10,376 (-23.5%), from €44,130 to €33,755
- Reserves +€50,423
up €50,423 (+18.8%), from €268,603 to €319,026
of which Distributable reserves: +€50,423
- Trade debts +€13,854
up €13,854 (+36.3%), from €38,142 to €51,996
- Other debts +€10,671
up €10,671 (+10.6%), from €100,571 to €111,242
- Gross operating margin -€51,412
down €51,412 (-19.2%), from €267,136 to €215,724
- Staff costs +€6,845
up €6,845 (+5.5%), from €123,958 to €130,803
- Financial charges +€4,098
up €4,098 (+35.9%), from €11,426 to €15,524
- Taxes -€3,387
down €3,387 (-16.3%), from €20,787 to €17,399
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €489,384 | €565,154 | +€75,770 | +15.5% |
| Fixed assets | 21/28 | €29,601 | €33,911 | +€4,310 | +14.6% |
| Tangible fixed assets | 22/27 | €1,551 | €5,861 | +€4,310 | +277.8% |
| Plant, machinery and equipment | 23 | €1,095 | €5,861 | +€4,767 | +435.4% |
| Furniture and vehicles | 24 | €457 | - | -€457 | |
| Financial fixed assets | 28 | €28,050 | €28,050 | = | 0.0% |
| Current assets | 29/58 | €459,783 | €531,243 | +€71,460 | +15.5% |
| Stocks and contracts in progress | 3 | €86,061 | €99,399 | +€13,338 | +15.5% |
| Stocks | 30/36 | €86,061 | €99,399 | +€13,338 | +15.5% |
| Amounts receivable within one year | 40/41 | €113,134 | €164,051 | +€50,917 | +45.0% |
| Trade receivables | 40 | €91,252 | €126,415 | +€35,162 | +38.5% |
| Other amounts receivable | 41 | €21,882 | €37,636 | +€15,754 | +72.0% |
| Current investments | 50/53 | €34,705 | €34,705 | +€0 | 0.0% |
| Cash at bank and in hand | 54/58 | €181,753 | €199,333 | +€17,580 | +9.7% |
| Deferred charges and accrued income | 490/1 | €44,130 | €33,755 | -€10,376 | -23.5% |
| Total equity and liabilities | 10/49 | €489,384 | €565,154 | +€75,770 | +15.5% |
| Equity | 10/15 | €330,603 | €381,026 | +€50,423 | +15.3% |
| Contributions | 10/11 | €62,000 | €62,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Reserves | 13 | €268,603 | €319,026 | +€50,423 | +18.8% |
| Non-distributable reserves | 130/1 | €6,200 | €6,200 | = | 0.0% |
| Legal reserve | 130 | €6,200 | €6,200 | = | 0.0% |
| Tax-exempt reserves | 132 | €93,000 | €93,000 | = | 0.0% |
| Distributable reserves | 133 | €169,403 | €219,826 | +€50,423 | +29.8% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €158,781 | €184,129 | +€25,347 | +16.0% |
| Amounts payable within one year | 42/48 | €158,030 | €179,583 | +€21,553 | +13.6% |
| Trade debts | 44 | €38,142 | €51,996 | +€13,854 | +36.3% |
| Suppliers | 440/4 | €38,142 | €51,996 | +€13,854 | +36.3% |
| Taxes, remuneration and social security | 45 | €19,317 | €16,345 | -€2,972 | -15.4% |
| Taxes | 450/3 | €2,081 | €4 | -€2,076 | -99.8% |
| Remuneration and social security | 454/9 | €17,237 | €16,341 | -€896 | -5.2% |
| Other amounts payable | 47/48 | €100,571 | €111,242 | +€10,671 | +10.6% |
| Accrued charges and deferred income | 492/3 | €751 | €4,546 | +€3,795 | +505.3% |
| Remuneration, social security and pensions | 62 | €123,958 | €130,803 | +€6,845 | +5.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,880 | €1,620 | -€260 | -13.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €337 | +€337 | |
| Other operating charges | 640/8 | €970 | €1,192 | +€222 | +22.9% |
| Gross operating margin | 9900 | €267,136 | €215,724 | -€51,412 | -19.2% |
| Operating profit (loss) | 9901 | €140,329 | €81,773 | -€58,556 | -41.7% |
| Financial income | 75/76B | €0 | €1,573 | +€1,573 | +3932550.0% |
| Recurring financial income | 75 | €0 | €1,573 | +€1,573 | +3932550.0% |
| Financial charges | 65/66B | €11,426 | €15,524 | +€4,098 | +35.9% |
| Recurring financial charges | 65 | €11,426 | €15,524 | +€4,098 | +35.9% |
| Profit (loss) for the period before taxes | 9903 | €128,903 | €67,822 | -€61,081 | -47.4% |
| Income taxes | 67/77 | €20,787 | €17,399 | -€3,387 | -16.3% |
| Profit (loss) for the period | 9904 | €108,116 | €50,423 | -€57,694 | -53.4% |
| Profit (loss) for the period to be appropriated | 9905 | €108,116 | €50,423 | -€57,694 | -53.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.